State Key Laboratory of Molecular Vaccine and Molecular Diagnostics, School of Public Health, Xiamen University, China; Key Laboratory of Health Technology Assessment of Fujian Province, School of Public Health, Xiamen University, China.
State Key Laboratory of Molecular Vaccine and Molecular Diagnostics, School of Public Health, Xiamen University, China; Key Laboratory of Health Technology Assessment of Fujian Province, School of Public Health, Xiamen University, China; National Institute for Data Science in Health and Medicine, Xiamen University, China.
Cancer Epidemiol. 2022 Feb;76:102068. doi: 10.1016/j.canep.2021.102068. Epub 2021 Dec 2.
Cancer creates considerable challenges for China with its aging population. This analysis aimed to estimate the burden of cancer and transition in cancer spectrum among older adults in China by 2030.
Using data from the National Central Cancer Registry of China, we estimated annual percent change (APC) in cancer incidence and mortality rates among adults aged 60 years and above between 2006 and 2015 using joinpoint regression. We further estimated the number of new cancer cases and deaths from 2020 to 2030 based on the APC and population projections.
Although cancer incidence and mortality rates have been decreasing among older adults in China between 2006 and 2015, there were marked increases in the incidence and mortality rates of cervical (incidence: APC = 9.2%, mortality: APC = 7.6% all p < 0.05) and thyroid cancers (incidence: APC = 9.3%, p < 0.05) in older women. Between 2015 and 2030, the number of new cancer cases is projected to increase by 46% from 2.2 million to 3.2 million; cancer deaths will increase by 31% from 1.6 million to 2.1 million among older Chinese adults. In 2015, the 3 most common cancers were lung, colorectal and breast cancer in women, and lung, colorectal and stomach cancer in men. By 2030, cervical cancer is projected to be the most common cancer in women, followed by lung and thyroid cancer; prostate cancer will surpass stomach cancer to become the third most common cancer in men. In both sexes, lung, liver and stomach cancer were the top 3 leading causes of cancer deaths in 2015. In women, cervical cancer will surpass lung cancer as the leading cause of cancer deaths by 2030.
The growing burden of cervical, thyroid and prostate cancer among older Chinese adults represents a major shift in cancer spectrum in this population.
癌症给中国这样一个人口老龄化的国家带来了巨大的挑战。本分析旨在预测到 2030 年,中国老年人群癌症负担和癌症谱变化情况。
利用中国国家癌症中心的数据,我们采用 joinpoint 回归分析了 2006 年至 2015 年期间 60 岁及以上成年人的癌症发病率和死亡率的年变化百分比(APC)。我们进一步根据 APC 和人口预测,估算了 2020 年至 2030 年的新发病例和死亡人数。
尽管中国老年人群的癌症发病率和死亡率在 2006 年至 2015 年期间呈下降趋势,但老年女性的宫颈癌(发病率:APC=9.2%,死亡率:APC=7.6%,均 P<0.05)和甲状腺癌(发病率:APC=9.3%,P<0.05)的发病率和死亡率显著上升。预计到 2030 年,中国老年癌症新发病例数将从 220 万增加到 320 万,增长 46%;癌症死亡人数将从 160 万增加到 210 万,增长 31%。2015 年,女性中最常见的三种癌症是肺癌、结直肠癌和乳腺癌,男性中则是肺癌、结直肠癌和胃癌。到 2030 年,宫颈癌预计将成为女性中最常见的癌症,其次是肺癌和甲状腺癌;前列腺癌将超过胃癌,成为男性中第三常见的癌症。在男女两性中,肺癌、肝癌和胃癌是 2015 年癌症死亡的前三大原因。到 2030 年,宫颈癌将超过肺癌,成为女性癌症死亡的主要原因。
在中国老年人群中,宫颈癌、甲状腺癌和前列腺癌的负担日益增加,这标志着该人群癌症谱发生了重大变化。